ROSA MARÍA AYALA DÍAZ-rekin lankidetzan egindako argitalpenak (8)

2023

  1. Posttranslational splicing modifications as a key mechanism in cytarabine resistance in acute myeloid leukemia

    Leukemia, Vol. 37, Núm. 8, pp. 1649-1659

2022

  1. Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. Monitoring of clonal evolution of acute myeloid leukemia identifies the leukemia subtype, clinical outcome and potential new drug targets for post-remission strategies or relapse

    Haematologica, Vol. 106, Núm. 9, pp. 2325-2333

2020

  1. Improving the prediction of acute myeloid leukaemia outcomes by complementing mutational profiling with ex vivo chemosensitivity

    British Journal of Haematology, Vol. 189, Núm. 4, pp. 672-683

2019

  1. A novel deep targeted sequencing method for minimal residual disease monitoring in acute myeloid leukemia

    Haematologica, Vol. 104, Núm. 2, pp. 288-296

  2. MEK inhibition enhances the response to tyrosine kinase inhibitors in acute myeloid leukemia

    Scientific reports, Vol. 9, Núm. 1, pp. 18630

  3. Protein carbonylation in patients with myelodysplastic syndrome: An opportunity for deferasirox therapy

    Antioxidants, Vol. 8, Núm. 11

  4. Ruxolitinib in combination with prednisone and nilotinib exhibit synergistic effects in human cells lines and primary cells from myeloproliferative neoplasms

    Haematologica, Vol. 104, Núm. 5, pp. 937-946